about
Connecting molecular pathways to hereditary cancer risk syndromesAssociation of the germline TP53 R337H mutation with breast cancer in southern Brazil.Development and validation of a simple questionnaire for the identification of hereditary breast cancer in primary care.A pathogenic mosaic TP53 mutation in two germ layers detected by next generation sequencing.The profile and contribution of rare germline copy number variants to cancer risk in Li-Fraumeni patients negative for TP53 mutations.TP53 mutations in human cancers: origins, consequences, and clinical useOrganization and running of the first comprehensive hereditary cancer clinic in India.Eligibility for magnetic resonance imaging screening in the United Kingdom: effect of strict selection criteria and anonymous DNA testing on breast cancer incidence in the MARIBS Study.Interpreting whole genome and exome sequencing data of individual gastric cancer samples.Anaplastic rhabdomyosarcoma in TP53 germline mutation carriersLate onset Li-Fraumeni Syndrome with bilateral breast cancer and other malignancies: case report and review of the literature.Li-Fraumeni-like syndrome associated with a large BRCA1 intragenic deletion.Tumor protein p53 (TP53) testing and Li-Fraumeni syndrome : current status of clinical applications and future directions.Li-Fraumeni syndrome--a molecular and clinical review.Population prevalence of hereditary breast cancer phenotypes and implementation of a genetic cancer risk assessment program in southern BrazilA risk of essential thrombocythemia in carriers of constitutional CHEK2 gene mutationsProspective comparison of family medical history with personal genome screening for risk assessment of common cancers.Using a family history questionnaire to identify adult patients with increased genetic risk for sarcoma.Two Li-Fraumeni syndrome families with novel germline p53 mutations: loss of the wild-type p53 allele in only 50% of tumours.Early onset HER2-positive breast cancer is associated with germline TP53 mutations.Prevalence of germline TP53 mutations in a prospective series of unselected patients with adrenocortical carcinomaNumber of rare germline CNVs and TP53 mutation types.P53 germline mutations in childhood cancers and cancer risk for carrier individualsThe value of rapid functional assays of germline p53 status in LFS and LFL familiesIncidence of multiple primary cancers in a cohort of women diagnosed with breast cancer in southeast EnglandLi-Fraumeni syndrome: report of a clinical research workshop and creation of a research consortiumA case of late-onset Li-Fraumeni-like syndrome with unilateral breast cancerGenetic counseling and testing for common hereditary breast cancer syndromes: a paper from the 2007 William Beaumont hospital symposium on molecular pathology.Early-onset breast cancer patients in the South and Southeast of Brazil should be tested for the TP53 p.R337H mutationScreening for germline BRCA1, BRCA2, TP53 and CHEK2 mutations in families at-risk for hereditary breast cancer identified in a population-based study from Southern Brazil.Li-Fraumeni SyndromeHigh frequency of germline TP53 mutations in a prospective adult-onset sarcoma cohort.The contribution of CHEK2 to the TP53-negative Li-Fraumeni phenotype.Predictive diagnosis of the cancer prone Li-Fraumeni syndrome by accident: new challenges through whole genome array testing.Regional differences in breast cancer biomarkers in american Indian and Alaska native women.Age at cancer onset in germline TP53 mutation carriers: association with polymorphisms in predicted G-quadruplex structures.TP53 p.R337H prevalence in a series of Brazilian hereditary breast cancer families.Breast cancer in patients with Li-Fraumeni syndrome - a case-series study and review of literature.Estimating TP53 Mutation Carrier Probability in Families with Li-Fraumeni Syndrome Using LFSPRO.Risks of first and subsequent cancers among TP53 mutation carriers in the National Cancer Institute Li-Fraumeni syndrome cohort.
P2860
Q28291516-26D4800C-0A1B-4897-8E34-27B15E459756Q33388533-13786A40-C201-4DF4-8D13-947A704159CDQ33493584-8E87EA10-4FBC-4320-8F3C-7F3D58E66557Q33583996-7E684F0F-F40E-4AC9-980C-BEFDBC9648F5Q33615771-AB089A0F-9F5D-435B-B42A-B8C448A4BF19Q33685392-B0F742EB-55CE-4ACE-8171-A5F146BD76F4Q33721559-FDCDD16B-3F47-468E-98AD-D806736184E1Q33847327-ED0EA137-6CDA-42FD-9819-2683651E93F3Q33882869-4B9DCF93-1EE8-49FF-8335-6ABA6C8E1633Q34235576-AFC627FA-403B-44AE-B34A-FDCCEB46E89DQ34294432-4D537840-EC38-4180-B138-D1724A8E58B3Q34301309-946F49C3-3681-4717-9BB4-9B1E2205F4AAQ34324683-09FF6307-789F-40C0-9012-FC8E542130D3Q34432117-CDF95723-7285-47C1-A0AC-2774FE8139E2Q34562565-E496AFD0-63E5-4C3C-86A4-5F59B2A1AA90Q35794421-39ECA00C-8024-4208-9B8F-CA551C0EAB04Q35899320-B0C1916E-DD8E-44C9-A9F1-B50D9C7CD5EBQ36169808-04AA070B-D835-46B0-A081-10C1BBC8FCF9Q36292302-5F5BC229-D715-4388-9572-351DB8CDC1FFQ36481648-34EE05CD-1FA6-403C-A4E7-E0C74B1F6466Q36508843-9A82A0E7-14EE-4FF1-8766-4AF79AF7DD1AQ36572009-566A9621-CD92-4C31-8865-58941DF97C24Q36621004-8EDC182C-EF8A-4C26-BCBB-EE0260CCDA29Q36621327-62310B8D-1057-47AB-813D-5B7616FA0C11Q36622589-6ABD915C-9305-4BE4-969B-596A52F09068Q36672536-27AE6E6F-1F9E-453F-8FB4-E93ED2C233A8Q36821830-49F5C4DA-B811-48FA-8CB1-289E83D0E517Q36843211-34625A02-D40B-40DB-898A-821A53BA95B8Q37011925-27DC2A91-834E-442A-903E-95AF8A2E5709Q37011944-637DE7DC-8440-49FF-A472-CF98DE23A25CQ37032644-C79B256F-3EDA-4D60-91D9-1B56638C65B0Q37033772-B8A92DBF-FD6E-475B-AA68-84B21A69FF47Q37147694-03E8250C-45DE-49D7-8D67-4A74E2D838A1Q37160436-9F9B96FD-D8FF-4DB2-8CF7-B3665CD1E583Q37638649-CAFA4B4A-3B6E-4395-95E5-FE23915D1895Q37687337-B17276BF-B55E-4B62-AF1C-1AC6C1C3DB2DQ37716648-7E8C0F07-730F-499F-9DD1-CF42C70D5FD9Q37722958-45D315F3-AF16-460D-9FA8-C2DC001319F8Q38764208-9E583768-E57A-49B9-85FA-E964C1284A00Q40633720-580F9611-35A7-464B-B9F0-C8983D78DB25
P2860
description
1995 nî lūn-bûn
@nan
1995 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1995 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
name
Germline mutations in the TP53 gene.
@ast
Germline mutations in the TP53 gene.
@en
Germline mutations in the TP53 gene.
@nl
type
label
Germline mutations in the TP53 gene.
@ast
Germline mutations in the TP53 gene.
@en
Germline mutations in the TP53 gene.
@nl
prefLabel
Germline mutations in the TP53 gene.
@ast
Germline mutations in the TP53 gene.
@en
Germline mutations in the TP53 gene.
@nl
P1433
P1476
Germline mutations in the TP53 gene.
@en
P2093
P304
P407
P577
1995-01-01T00:00:00Z